Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Apheresis|November 25, 2021
Successful "on-demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumorsAndrea Corbingi, Elisabetta Metafuni, Mariantonietta Di Salvatore, et al.
Hepato-Gastroenterology|March 13, 2003
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic eventsAlfredo Papa, Silvio Danese, Nicola Piccirillo, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Posttransplant Autoimmune Hemolytic Anemia with Anti-D Specificity Successfully Treated with Daratumumab: A Case ReportFilippo Frioni, Elisabetta Metafuni, Maria Assunta Limongiello, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre ExperienceLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
Leukemia Research|January 22, 2008
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndromeLuca Laurenti, Silvia De Matteis, Mario Sabatelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian CentersFrancesco Autore, Nicola Piccirillo, Andrea Nozza, et al.
Annals of Hematology|July 1, 2008
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response durationLuca Laurenti, Michela Tarnani, Laura De Padua, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescuePatrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, et al.
Annals of Hematology|July 14, 2010
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcomeLuca Laurenti, Laura De Padua, Michela Tarnani, et al.
Blood Transfusion = Trasfusione Del Sangue|May 5, 2023
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert PanelGiovanna Leone, Valentina Baldini, Stefania Bramanti, et al.
Pageof 5